Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
25-50 µM
Hemolytic
Cytotoxic
50% Hemolysis | 25-50 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Ab initio design of potent anti-MRSA peptides based on database filtering technology. | J Am Chem Soc | 2012